So-Young enters pact with Healtech to develop supply chain business

So-Young announced that it has entered into a strategic partnership with Healtech, a fully-integrated contract research organization, or CRO, and contract manufacturing organization, or CMO, for the pharmaceutical industry in China, to jointly develop two regenerative medical aesthetic products and further expand its supply chain business. Under the terms of the strategic partnership, So-Young and Healtech will begin by jointly developing a silk fibroin-hyaluronic acid compound solution and an extracellular matrix bio gel injectable filler. Leveraging So-Young’s trusted reputation and deep industry insights, and Healtech’s strong R&D capabilities, both two parties will work together to create new regenerative medical aesthetic products.